I'm not sure I'd call them competitors. Yes they both take your spit and process it, yes they both allow you to see potential extended family but that's about the only similarities.
Ancestry added it as an extension of their genealogical services while 23andme was originally for personal medical discovery before the FDA came down on them and they had to change tactics.
While there are legitimate concerns, 23&Me is pretty good in terms of privacy practices and their founders/employees are working in good faith to improve the health of humans. It's kind of sad that gets twisted into "compabnies are profiting from your personal data", because while that is true, it's not nearly as invasive or gattaca as people seem to think.
But we all understand that technology is only going to make more information available from those samples over time. The board has a fiduciary responsibility to its shareholders, and it doesn't take a great imagination to see that if the information becomes valuable in new ways then there will be pressure to use it however they can.
What we have here is a baby step.
Ancestry is not 23andme’s owner. They are competitors.
23andMe ask you during sign up if you wish to take part of anonymized research. They ask you again for each person whose sample you submit. You can also opt out at any time.
The article author even knows this, since when they asked Ancestry (23AndMe's owner) that was exactly what they were told. So why does the article have such a hyperbolic tone and misleading information?
I don't have high expectations for Business Insider but this article still disappoints me. This is tabloid level "journalism."